Literature DB >> 22872489

Expression profile of extracellular matrix and adhesion molecules in the development of endometriosis in a mouse model.

Masakazu Umezawa1, Yumi Saito, Naomi Tanaka-Hattori, Ken Takeda, Tomomi Ihara, Masao Sugamata.   

Abstract

Ectopic endometrial tissue induces various reactions in surrounding tissues, such as the surface of the ovary and peritoneal cavity, leading to endometriosis. The aim of this study is to investigate the expression profile of extracellular matrix (ECM) and adhesion molecules in the early steps of development of experimental mouse endometriosis, specifically in peritoneum adjacent to endometrium transplants attached via autotransplantation. The endometriosis model was induced by autotransplantation of endometrium to peritoneal tissue. Peritoneal tissues adjacent to the transplant were obtained at 1, 4, and 7 days posttransplantation. The results showed that messenger RNA expression levels of most of the integrins, collagens, and other ECM reached a peak at 7 days posttransplantation. Uniquely, Lamc2 was significantly increased to its maximum level within 24 hours posttransplantation and may be strongly associated with initiation of the development of endometriosis. These data will be helpful in further investigations of the treatment of endometriosis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22872489     DOI: 10.1177/1933719112450340

Source DB:  PubMed          Journal:  Reprod Sci        ISSN: 1933-7191            Impact factor:   3.060


  9 in total

1.  Effect of induced peritoneal endometriosis on oocyte and embryo quality in a mouse model.

Authors:  J Cohen; A Ziyyat; I Naoura; N Chabbert-Buffet; S Aractingi; E Darai; B Lefevre
Journal:  J Assist Reprod Genet       Date:  2014-11-16       Impact factor: 3.412

2.  Effect of traditional Chinese medicine (Xiaochaihu Tang) on the expression of MMP-2 and MMP-9 in rats with endometriosis.

Authors:  Luyang Jiao; Xiaofen Qi; Guangjian Lu; Qunmei Zhang; Chunxiao Zhang; Jianhui Gao
Journal:  Exp Ther Med       Date:  2013-09-26       Impact factor: 2.447

3.  Expression of the gamma 2 chain of laminin-332 in eutopic and ectopic endometrium of patients with endometriosis.

Authors:  Rosella Locci; Michelle Nisolle; Stefano Angioni; Jean-Michel Foidart; Carine Munaut
Journal:  Reprod Biol Endocrinol       Date:  2013-09-26       Impact factor: 5.211

4.  Discovery of non-invasive biomarkers for the diagnosis of endometriosis.

Authors:  Stella Irungu; Dimitrios Mavrelos; Jenny Worthington; Oleg Blyuss; Ertan Saridogan; John F Timms
Journal:  Clin Proteomics       Date:  2019-04-06       Impact factor: 3.988

5.  hsa-miR-340-5p inhibits epithelial-mesenchymal transition in endometriosis by targeting MAP3K2 and inactivating MAPK/ERK signaling.

Authors:  Yiting Wan; Jiami Huang; Yanhua Song; Cancan Gu; Jueying Kong; Ling Zuo; Jing Chen
Journal:  Open Med (Wars)       Date:  2022-03-17

6.  Endometriosis: Epidemiology, Diagnosis and Clinical Management.

Authors:  Parveen Parasar; Pinar Ozcan; Kathryn L Terry
Journal:  Curr Obstet Gynecol Rep       Date:  2017-01-27

7.  Transforming growth factor β1 enhances adhesion of endometrial cells to mesothelium by regulating integrin expression.

Authors:  Hee-Jung Choi; Mi-Ju Park; Bo-Sung Kim; Hee-Jin Choi; Bosun Joo; Kyu Sup Lee; Jung-Hye Choi; Tae-Wook Chung; Ki-Tae Ha
Journal:  BMB Rep       Date:  2017-08       Impact factor: 4.778

Review 8.  Endometriosis Associated Infertility: A Critical Review and Analysis on Etiopathogenesis and Therapeutic Approaches.

Authors:  Lidia Filip; Florentina Duică; Alina Prădatu; Dragoș Crețoiu; Nicolae Suciu; Sanda Maria Crețoiu; Dragoș-Valentin Predescu; Valentin Nicolae Varlas; Silviu-Cristian Voinea
Journal:  Medicina (Kaunas)       Date:  2020-09-09       Impact factor: 2.430

9.  Expression of cellular adherent and invasive molecules in recurrent ovarian endometriosis.

Authors:  Tingting Wu; Rongyan Zhang; Qiaoying Jiang; Zhi Li; Ruijin Wu
Journal:  J Int Med Res       Date:  2020-11       Impact factor: 1.671

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.